SISAQOL Trademark

Serial Number: 99560444

SISAQOL is a trademark filed by ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER, in short EORTC on December 22, 2025. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Details

Filing Date

December 22, 2025

Registration Date

Not Registered

Goods & Services

Medical consultancy and advisory services relating to patient-reported outcomes (PROs), including their use in clinical practice and treatment evaluation; Providing medical information related to PROs; Providing medical information and guidance to healthcare professionals on interpreting and applying patient-reported outcomes (PROs) data in oncology and other therapeutic areas; Medical consultancy in the field of patient-centered care and medical outcomes assessment; Medical consultancy relating to the support of personalized treatment planning through the structured use of patient-reported outcomes (PROs) frameworks

Arranging of educational conferences, workshops and training sessions in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing online non-downloadable electronic publications in the form of books, journals, articles, reports, educational materials, transcripts and graphs in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing training in the fields of reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice; providing recommendations on literature relating to the reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice

Scientific and technological services, namely, the development and testing of methodologies for the design, analysis, interpretation, and presentation of patient-reported outcomes (PROs) in clinical trials or other medical research; Research and design of standardized data analysis frameworks in oncology and other therapeutic areas; Providing scientific information, clinical research support advice and consultancy relating to patient-reported outcomes (PROs) and health-related quality of life (HRQOL); Development of software tools for the implementation of patient-reported outcomes (PROs) in health-related research; hosting and maintenance of online platforms and non-downloadable software for others in the field of patient-reported outcomes (PROs) methodology implementation

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 20, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 19, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 19, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jul 19, 2026 CNSL
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 19, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 19, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 19, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 19, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 22, 2025 MAFR
NEW APPLICATION ENTERED
Dec 22, 2025 NWAP